Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | BCL2 | P10415 | 1/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.40 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11785179 | 0.74 | MEN1 (0.54) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL30024208 | 0.74 | MEN1 (0.59) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL11311046 | 0.74 | ALOX15 (0.41) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL27626950 | 0.72 | HIF1A (0.79) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL11785185 | 0.71 | BCL2 (0.56) | MEN1KMT2AALOX15CYP3A4HPGD | |
| SCHEMBL1683378 | 0.71 | KMT2A (0.47) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL11260186 | 0.71 | MEN1 (0.65) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL10982291 | 0.70 | MAPT (0.50) | MAPTMEN1KMT2AALOX15CYP3A4 | |
| SCHEMBL28623712 | 0.70 | HPGD (0.46) | MAPTALOX15CYP3A4HPGDHIF1A | |
| SCHEMBL11685074 | 0.69 | MEN1 (0.53) | MAPTMEN1KMT2AALOX15CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086823-A1 | DISINFECTANT | BAYER ANIMAL HEALTH GMBH (DE) | 2011-04-14 | — | — | US | claimed |
| US-20080221222-A1 | Disinfectant | BAYER HEALTHCARE LLC (DE) | 2008-09-11 | — | — | US | claimed |
| EP-1909569-A2 | DISINFECTING AGENT CONTAINING A COMBINATION OF BIOCIDAL PHENOLS AND A KERATOLYTIC | Bayer HealthCare AG (DE) | 2008-04-16 | — | — | EP | claimed |
| WO-2007009606-A2 | DISINFECTING AGENT CONTAINING A COMBINATION OF BIOCIDAL PHENOLS AND A KERATOLYTIC | BAYER HEALTHCARE AG (DE) | 2007-01-25 | — | — | WO | claimed |
| EP-2310018-B1 | USE OF NIFURTIMOX FOR TREATING GIARDIASIS | BAYER IP GMBH (DE) | 2013-12-18 | — | — | EP | disclosed |
| US-8440612-B2 | Controlling giardiosis | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-05-14 | — | — | US | disclosed |
| US-20110168623-A1 | FEED SIDE PASSAGE MATERIAL AND SPIRAL SEPARATION MEMBRANE ELEMENT | NITTO DENKO CORPORATION (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110105388-A1 | NOVEL POSSIBILITY OF CONTROLLING GIARDIOSIS | BAYER ANIMAL HEALTH GMBH (DE) | 2011-05-05 | — | — | US | disclosed |
| EP-2310018-A1 | USE OF NIFURTIMOX FOR TREATING GIARDIASIS | Bayer Animal Health GmbH (DE) | 2011-04-20 | — | — | EP | disclosed |
| US-20110086823-A1 | DISINFECTANT | BAYER ANIMAL HEALTH GMBH (DE) | 2011-04-14 | — | — | US | disclosed |
| WO-2010000399-A1 | USE OF NIFURTIMOX FOR TREATING GIARDIASIS | BAYER ANIMAL HEALTH GMBH (DE) | 2010-01-07 | — | — | WO | disclosed |
| US-20080221222-A1 | Disinfectant | BAYER HEALTHCARE LLC (DE) | 2008-09-11 | — | — | US | disclosed |
| EP-1909569-A2 | DISINFECTING AGENT CONTAINING A COMBINATION OF BIOCIDAL PHENOLS AND A KERATOLYTIC | Bayer HealthCare AG (DE) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007009606-A2 | DISINFECTING AGENT CONTAINING A COMBINATION OF BIOCIDAL PHENOLS AND A KERATOLYTIC | BAYER HEALTHCARE AG (DE) | 2007-01-25 | — | — | WO | disclosed |
| EP-1380208-B1 | Disinfectant agent with antiparasitic activity | EWABO CHEMIKALIEN GMBH (DE) | 2005-06-29 | — | — | EP | disclosed |
| EP-1380208-A1 | Disinfectant agent with antiparasitic activity | Ewabo Chemikalien GmbH (DE) | 2004-01-14 | — | — | EP | disclosed |
| US-5620655-A | MIXTURE OF A PHENOL COMPOUND AND ORGANIC ACID | MENNO-CHEMIE-VERTRIEB GMBH (DE) | 1997-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105388-A1 | NOVEL POSSIBILITY OF CONTROLLING GIARDIOSIS | TNNI3, PIGO, GLRX3 | MAPT 4798/4885MEN1 2736/4885KMT2A 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.